Liang Wenquan, Zhou Zhengfang, Cui Jianxin, Xi Hongqing, Chen Lin
Department of General Surgery, Chinese PLA General Hospital, Chinese PLA Mecical School, Beijing 100853, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Mar 25;20(3):277-282.
To analyze relationships between the tumor deposits (TD) and clinicopathologic features of gastric cancer and investigate the value of TD in staging and prognosis in gastric cancer patients.
Retrospective cohort study was conducted to evaluate the clinicopathologic data of 388 gastric cancer patients who underwent surgical procedures in Chinese PLA General Hospital between November 2011 and December 2012. Relationships between TD and clinicopathologic features were analyzed by χ or Fisher exact tests. Survival curves were also generated by Kaplan-Meier method. The univariate and multivariate analysis were performed with Log-rank and COX proportional hazard model to examine the association between prognosis and TD.
TD were observed in 67 (17.3%) of 388 gastric cancer patients, including 48 male patients (48/289, 16.6%) and 19 female patients (19/99, 19.2%). There were 40 patients (40/198, 20.2%) whose age was above 64 years old. TNM staging of positive TD patients was as follows: for pathology, there were 5 patients (5/64, 7.8%) in stage II(b, 6 patients (6/58, 10.3%) in stage III(a, 14 patients (14/75, 18.7%) in stage III(b, 30 patients (30/135, 22.2%) in stage III(c, 12 patients (12/39, 30.8%) in stage IIII( and no one in stage I(b or II(a; for T-staging, there were 2 patients (2/18, 11.1%) in stage T2, 2 patients (2/27, 7.4%) in stage T3, 36 patients (36/259, 13.9%) in stage T4a and 27 patients (27/84, 32.1%) in stage T4b; for N-stage, there were 5 patients (5/72, 6.9%) in stage N0, 6 patients (6/72, 8.3%) in stage N1, 19 patients (19/82, 23.2%) in stage N2, 27 patients (27/100, 27.0%) in stage N3a and 10 patients(10/62, 16.1%) in stage N3b; for M-stage, there were 12 patients (12/40, 30.0%) in distal metastases; for vascular invasion, there were 29 patients (29/129, 22.5%). Among positive TD patients, the number of TD >3 was found in 38 of 67 cases(56.7%). TD was associated with pTNM-stage (χ=16.898, P=0.010), T-stage (χ=17.382, P=0.001), N-stage (χ=18.080, P=0.001), M-stage (χ=5.060, P=0.036) and vascular invasion(χ=3.675, P=0.039). The median survival time of positive TD patients was significantly shorter as compared to negative TD patients (22 months vs. 32 months, χ=23.391, P=0.012). Among positive TD patients, the median survival time of patients with TD number >3 was significantly shorter as compared to those with TD number <3 (17 months vs. 25 months, χ=5.157, P=0.023). Multivariate survival analysis showed that TD number >3 was the independent risk factor of prognosis (RR=2.350, 95%CI:1.345 to 4.106, P=0.003).
TD state is closely associated with the staging of gastric cancer and TD number >3 indicates a poor prognosis.
分析胃癌肿瘤沉积物(TD)与临床病理特征之间的关系,并探讨TD在胃癌患者分期及预后中的价值。
采用回顾性队列研究,评估2011年11月至2012年12月在中国人民解放军总医院接受手术的388例胃癌患者的临床病理资料。采用χ²检验或Fisher精确检验分析TD与临床病理特征之间的关系。采用Kaplan-Meier法绘制生存曲线。运用Log-rank检验和COX比例风险模型进行单因素和多因素分析,以检验预后与TD之间的关联。
388例胃癌患者中,67例(17.3%)观察到TD,其中男性患者48例(48/289,16.6%),女性患者19例(19/99,19.2%)。年龄大于64岁的患者有40例(40/198,20.2%)。TD阳性患者的TNM分期如下:病理分期方面,Ⅱ期(b)5例(5/64,7.8%),Ⅲ期(a)6例(6/58,10.3%),Ⅲ期(b)14例(14/75,18.7%),Ⅲ期(c)30例(30/135,22.2%),Ⅳ期12例(12/39,30.8%),Ⅰ期(b)或Ⅱ期(a)无病例;T分期方面,T2期2例(2/18,11.1%),T3期2例(2/27,7.4%),T4a期36例(36/259,13.9%),T4b期27例(27/84,32.1%);N分期方面,N0期5例(5/72,6.9%),N1期6例(6/72,8.3%),N2期19例(19/82,23.2%),N3a期27例(27/100,27.0%),N3b期10例(10/62,16.1%);M分期方面,远处转移12例(12/40,30.0%);血管侵犯29例(29/129,22.5%)。在TD阳性患者中,67例中有38例(56.7%)TD>3。TD与pTNM分期(χ²=16.898,P=0.010)、T分期(χ²=17.382,P=0.001)、N分期(χ²=18.080,P=0.001)、M分期(χ²=5.060,P=0.036)及血管侵犯(χ²=3.675,P=0.039)相关。TD阳性患者的中位生存时间明显短于TD阴性患者(22个月对32个月,χ²=23.391,P=0.012)。在TD阳性患者中,TD数量>3的患者中位生存时间明显短于TD数量<3的患者(17个月对25个月,χ²=5.157,P=0.023)。多因素生存分析显示,TD数量>3是预后的独立危险因素(RR=2.350,95%CI:1.345至4.106,P=0.003)。
TD状态与胃癌分期密切相关,TD数量>3提示预后不良。